ECSP045053A - PHARMACEUTICAL COMPOSITIONS THAT INCLUDE MYCOPHENOLIC ACID OR MYCOPHENOLATE SALT - Google Patents

PHARMACEUTICAL COMPOSITIONS THAT INCLUDE MYCOPHENOLIC ACID OR MYCOPHENOLATE SALT

Info

Publication number
ECSP045053A
ECSP045053A ECSP045053A ECSP045053A EC SP045053 A ECSP045053 A EC SP045053A EC SP045053 A ECSP045053 A EC SP045053A EC SP045053 A ECSP045053 A EC SP045053A
Authority
EC
Ecuador
Prior art keywords
mycophenolic acid
pharmaceutical compositions
mycophenolate salt
include mycophenolic
mycophenolate
Prior art date
Application number
Other languages
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40435091&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP045053(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Priority to ECSP045053 priority Critical patent/ECSP045053A/en
Publication of ECSP045053A publication Critical patent/ECSP045053A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención proporciona una forma de dosis sólida, por ejemplo, una tableta, que comprende ácido micofenólico o una sal de micofenolato y un procedimiento para su producción.The invention provides a solid dosage form, for example, a tablet, comprising mycophenolic acid or a mycophenolate salt and a method for its production.

ECSP045053 2004-04-08 2004-04-08 PHARMACEUTICAL COMPOSITIONS THAT INCLUDE MYCOPHENOLIC ACID OR MYCOPHENOLATE SALT ECSP045053A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP045053 ECSP045053A (en) 2004-04-08 2004-04-08 PHARMACEUTICAL COMPOSITIONS THAT INCLUDE MYCOPHENOLIC ACID OR MYCOPHENOLATE SALT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP045053 ECSP045053A (en) 2004-04-08 2004-04-08 PHARMACEUTICAL COMPOSITIONS THAT INCLUDE MYCOPHENOLIC ACID OR MYCOPHENOLATE SALT

Publications (1)

Publication Number Publication Date
ECSP045053A true ECSP045053A (en) 2004-05-28

Family

ID=40435091

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP045053 ECSP045053A (en) 2004-04-08 2004-04-08 PHARMACEUTICAL COMPOSITIONS THAT INCLUDE MYCOPHENOLIC ACID OR MYCOPHENOLATE SALT

Country Status (1)

Country Link
EC (1) ECSP045053A (en)

Similar Documents

Publication Publication Date Title
ECSP024341A (en) PHARMACEUTICAL COMPOSITIONS
UY30712A1 (en) NEW DERIVATIVES OF 1, 4-BENZOTIEPINA-1, 1-DIOXIDE REPLACED WITH FLUOR, METHOD FOR PREPARATION, PHARMACEUTICAL PRODUCTS THAT UNDERSTAND THESE COMPOUNDS AND THEIR USE.
AP2405A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms.
UY30711A1 (en) NEW DERIVATIVES OF 1,4-BENZOTIEPINA-1, 1-CIOXIDE, METHOD FOR PREPARATION, PHARMACEUTICAL PRODUCTS THAT INCLUDE THESE COMPOUNDS AND THEIR USE.-
ECSP11011307A (en) TABLETS FOR COMBINATION THERAPY
CY1122777T1 (en) SOLID PHARMACEUTICAL DOSAGE FORM CONTAINING LOPINAVIR
EP3398948A3 (en) 2,4,6,7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
UY30710A1 (en) NEW DERIVATIVES OF 1,4-BENZOTIEPINA-1,1-DIOXIDE REPLACED WITH CYCLHEXYL RADICALS, METHOD FOR THEIR PREPARATION, PHARMACEUTICAL PRODUCTS THAT INCLUDE THESE COMPOUNDS AND THEIR USE.
CL2007003797A1 (en) COMPOUNDS DERIVED FROM PIRROLO PIRIDINA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF THE DISEASE OF ALZHEIMER, PARKINSON, CANCER, AMONG OTHER ILLNESSES.
FR2883179B1 (en) COATED TABLET
BRPI0520669A2 (en) pharmaceutical dosage that reduces the effect of food found for atorvastatin administration
ECSP077999A (en) FORMULATIONS OF A MODIFIED LIBERATION BUPROPION SALT
CO2017013293A2 (en) Pharmaceutical formulations comprising tenofovir and emtricitabine
BRPI0814957A2 (en) COMPOUND, PRODUCT, PHARMACEUTICAL AGENT, METHOD FOR PROPHYLAXY OR TREATMENT OF A DISEASE, DISORDER OR CONDITION, AND USE OF THE COMPOUND.
CO6470841A2 (en) SOLID PREPARATION THAT PRESENTS PROPERTY OF IMPROVED DISSOLUTION OF A MEDICINAL PRODUCT FROM THE SAME
BR112012003280A2 (en) pharmaceutical composition for oral administration, method for treating a disease, use of the compound, and, compound.
BRPI0717369A2 (en) COMPOUND, MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND.
EA201000039A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING SOLIFENACIN OR ITS PHARMACEUTICALLY ADAPTABLE SALT
PA8781501A1 (en) FORMATION OF PASSIREOTIDE
BRPI0812871A2 (en) "CONTAINER, AND METHOD FOR FORMING THE SAME".
TNSN07453A1 (en) Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases
CL2008000093A1 (en) COMPOUNDS DERIVED FROM PIRIDINA, INHIBITORS OF P2Y12; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF A PLAQUETARY AGREGATION DISORDER.
PL1845957T3 (en) Method for producing a drug extract that contains hydroxystilbenes
EP1900368A4 (en) TABLET CONTAINING AN ACTIVE SOLUBLE INGREDIENT
BRPI0516464B8 (en) method for preparing a pharmaceutical product